Remove tag checkpoint-inhibitor
article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines. IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

This is in addition to its considerable price tag. Car-t “The living drugs”, immune checkpoint inhibitors, and precision medicine: A new era of cancer therapy. The demand for CAR T-cell therapy is therefore much greater than the supply, making it difficult for patients to access the potentially life-saving treatment. 2019;12(1).